A drug called Aviptadil shows promise in defeating the syndrome that accounts for around half of all corona-related deaths.
An Israeli company called Neurorx is currently testing a drug called Aviptadil, which could treat acute respiratory distress syndrome (ARDS), the condition responsible for around 50% of all coronavirus fatalities.
On Sunday, the U.S. Food and Drug Administration gave approval to NeuroRx for phase two trials of Aviptadil.
While this is not a complete drug approval for Covid-19-related use of the drug, it does mean the treatment is one step closer to getting the greenlight for patient use.
HELP ISRAELIS BATTLE CORONA!
Donate to the Corona Emergency Relief Fund. Coronavirus has taken a huge toll on the people of Israel. The poor, elderly and ill are most vulnerable.
Israeli soldiers, security officers and medical care providers operate under great danger and risk to life.